Janus kinase 2 inhibition by Licochalcone B suppresses esophageal squamous cell carcinoma growth

Phytotherapy Research : PTR
Mengqiu SongJung-Hyun Shim

Abstract

Esophageal cancer (EC) is one of the leading causes to cancer death in the worldwide and major population of EC is esophageal squamous cell carcinoma (ESCC). Still, ESCC-targeted therapy has not been covered yet. In the present study we have identified that Licochalcone B (Lico B) inhibited the ESCC growth by directly blocking the Janus kinase (JAK) 2 activity and its downstream signaling pathway. Lico B suppressed KYSE450 and KYSE510 ESCC cell growth, arrested cell cycle at G2/M phase and induced apoptosis. Direct target of Lico B was identified by kinase assay and verified with in vitro and ex vivo binding. Computational docking model predicted for Lico B interaction to ATP-binding pocket of JAK2. Furthermore, treatment of JAK2 clinical medicine AZD1480 to ESCC cells showed similar tendency with Lico B. Thus, JAK2 downstream signaling proteins phosphorylation of STAT3 at Y705 and S727 as well as STAT3 target protein Mcl-1 expression was decreased with treatment of Lico B. Our results suggest that Lico B inhibits ESCC cell growth, arrests cell cycle and induces apoptosis, revealing the underlying mechanism involved in JAK2/STAT3 signaling pathways after Lico B treatment. It might provide potential role of Lico B in the treatme...Continue Reading

References

Nov 23, 2006·European Journal of Medicinal Chemistry·Zdzisława Nowakowska
Jul 31, 2013·Archives of Pharmacal Research·Zengtao WangSeung Hoon Cheon
Oct 3, 2013·Asian Pacific Journal of Cancer Prevention : APJCP·Zhao-Ling SunPing Han
Oct 26, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jih-Hsiang LeeGiuseppe Giaccone
Jan 5, 2014·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Xuan YuanZhiping Wang
Oct 25, 2014·Nature Reviews. Cancer·Hua YuRichard Jove
Apr 1, 2015·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·Eun-Jung BakJeong-Heon Cha
Sep 12, 2015·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Yefang XuHongxia Li
Nov 18, 2015·Journal of Chemical Theory and Computation·James A MaierCarlos Simmerling
Jan 7, 2016·Journal of Cancer Prevention·Eun-Yi Ko, Aree Moon
Jan 9, 2016·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Jul 3, 2016·Seminars in Cancer Biology·Georgios KallifatidisBal L Lokeshwar
Oct 21, 2016·Annals of Thoracic and Cardiovascular Surgery : Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia·Satoru MatsudaYuko Kitagawa
Sep 28, 2016·Molecules and Cells·Soo Hwa JangIn-Seob Han
Oct 11, 2016·Recent Patents on Anti-cancer Drug Discovery·Lina YuQiusheng Zheng
May 14, 2017·Blood·Prithviraj Bose, Srdan Verstovsek
Jun 4, 2017·Molecular and Cellular Endocrinology·Bernd Groner, Viktoria von Manstein
Jun 6, 2017·Cytokine·Lidia AvalleValeria Poli
Jul 2, 2017·Diabetes·Kira MeyerovichAlessandra K Cardozo
Jul 28, 2017·Nature Reviews. Disease Primers·Elizabeth C SmythDavid Cunningham
Jan 10, 2018·Asia-Pacific Journal of Clinical Oncology·Yining YangJun Yu
Feb 20, 2018·Molecular Cancer·Manoj Kumar Kashyap, Omar Abdel-Rahman
Aug 3, 2018·Journal of Cellular Physiology·Ji-Hye SeoJung-Hyun Shim
Aug 18, 2018·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Hongzhi DuLi Sun
Oct 4, 2018·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Jing ZhuYinghui Huang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis